A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and disease

MM Higdon, B Wahl, CB Jones, JG Rosen, SA Truelove… - MedRXiv, 2021 - medrxiv.org
Billions of doses of COVID-19 vaccines have been administered globally, dramatically
reducing SARS-CoV-2 incidence and severity in some settings. Many studies suggest …

Adolescent vaccination with BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine and effectiveness against COVID-19: national test-negative case-control study, England

AA Powell, F Kirsebom, J Stowe, K McOwat, V Saliba… - MedRxiv, 2021 - medrxiv.org
Adolescents in the UK were recommended to have their first dose of mRNA vaccine during a
period of high community transmission due to the highly transmissible Delta variant …

SARS-CoV-2 anti-spike IgG antibody responses after second dose of ChAdOx1 or BNT162b2 and correlates of protection in the UK general population

J Wei, KB Pouwels, N Stoesser, PC Matthews… - medRxiv, 2021 - medrxiv.org
We investigated anti-spike IgG antibody responses and correlates of protection following
second doses of ChAdOx1 or BNT162b2 SARS-CoV-2 vaccines in the UK general …

[PDF][PDF] Quantifying the impact of delaying the second COVID-19 vaccine dose in England: a

N Imai, T Rawson, ES Knock, R Sonabend - Lancet, 2021 - scholar.archive.org
Background: The UK was the first country to start national COVID-19 vaccination
programmes, initially administering doses 3-weeks apart. However, early evidence of high …